and Venezuela. Using a logarithmic Poisson count data joinpoint model, we estimated number of deaths and age-standardized (world population) mortality rates in 2017.
Introduction
National cancer mortality data have been available for a few Latin American countries since the 1970s. These showed relatively low rates for common cancers, including lung, colorectum and breast, in most countries, and relatively high rates, but with downward trends, for stomach and (cervix) uteri [1, 2] .
Since death certification figures are available with a few years lag, predictions of cancer mortality for the current year have been published over several years for the USA [3] and the European Union (EU) [4] , and have proven reasonably valid [3, 5] . Thus, despite some inherent uncertainty in any prediction, these are useful for public health planning, and for understanding patterns and trends in cancer rates and hence their major risk factors.
We therefore predicted the number of deaths and mortality rates for all cancers and selected major cancer sites for 2017 in seven Latin America countries providing death certification data of acceptable validity to the World Health Organization (WHO) database.
Materials and methods
We retrieved official death certification data from the WHO database (WHOSIS) [6] for cancer of the stomach, colorectum, pancreas, lung, breast, uterus (cervix and corpus), prostate, leukaemias and total neoplasms (malignant and benign). We obtained data for the seven Latin American countries with over 85% death certification coverage (over 90% for all countries except Brazil) and over 10 million inhabitants (Argentina, Brazil, Chile, Colombia, Cuba, Mexico, and Venezuela) [7] , for the 1980-2014 calendar Table 1 . Number of predicted deaths and mortality rates per 100 000 men for the year 2017 and comparison figures for the year 2012, from selected Latin America countries, with 95% prediction intervals and percent differences [8] .
Using certified deaths and resident population, we calculated age-specific death rates for each 5-year age group (from 0-4 to 80þ years), sex and calendar year. We computed age-standardized rates per 100 000 person-years at all ages, using the direct method on the world standard population.
To identify the most recent trend segment, we fit a logarithmic Poisson count data joinpoint regression model to the number of certified deaths in each 5-year age group [9] allowing for up to five joinpoints. We then applied a linear regression to each age group's mortality data over the most recent trend segment identified by the joinpoint model to compute the predicted age-specific certified numbers of deaths and the corresponding 95% prediction intervals (PIs). We calculated the 95% PIs using a standard error accounting for the variability of the new observation [5, 10] . Predicted age-standardized death rates with their corresponding 95% PIs were estimated using the predicted age-specific death counts and the predicted population data from the PAHO database.
Number of avoided cancer deaths over the 1990-2017 period were estimated by comparing observed deaths and expected ones on the basis of the 1990 age-specific rates.
Results
Tables 1 (men) and 2 (women) include the number of predicted cancer deaths and rates for the year 2017 with the corresponding 95% PIs along with the 2012 observed data, and the percent difference between 2017 and 2012 for the seven countries and the nine cancer sites considered. Figure 1 shows bar plots of age-standardized death rates per 100 000 population for all cancers in the countries considered, in men and women, in 2012 [dark grey (blue online)], and the predicted rates for 2017 [light grey (pink online)], with corresponding 95% PIs. Total cancer mortality is predicted to decline in all countries. In men the highest predicted rate is 132.3/100 000 for Cuba. Mexican men have the lowest predicted total cancer rate, 64.7/100 000, and the largest fall in rates. In women, Cuba has the highest predicted rate 93.3/100 000, compared to 96.3 in 2012; Mexico has the lowest one, 60.6/100 000, compared to 65.8 in 2012. The greatest falls are predicted for Chile and Colombia.
Despite favourable trends in rates, the number of deaths is predicted to increase in all countries and both sexes (Tables 1 and 2 ). The largest increase is in Colombian men. Figure 2 shows trends in total cancer mortality rates, in men and women separately, from 1980-1984 quinquennium to 2010-2014, and predicted rates for 2017 with the corresponding PIs. In men, trends started to decline between 1990 and 2000, except for Cuba and Brazil. Female trends generally declined over the whole period considered, except for Cuba and Brazil. Figure 3 gives mortality trends for each cancer site by sex and country. In men, lung cancer trends were moderately downwards in recent calendar periods for most countries. Mexico and Argentina showed strong downward trends since 1990. In contrast, lung cancer trends in women have been rising, except in Mexico, with however some levelling only in recent years. Stomach cancer mortality has long been downwards. Colorectal cancer has been rising in most countries, with a tendency to level off during the most recent period. Breast cancer mortality was relatively low in most countries (except Argentina) and tended to decline over recent years. In contrast, despite long-term falls, cancer of the uterus rates remain high in all Latin America, particularly in Cuba and Venezuela, whose predicted rates remain around 10/100 000. Prostate cancer rates were particularly high in Cuba and Venezuela, but tended to moderately decline over the most recent years. While pancreatic cancer rates are inconsistent, leukaemias mortality shows some declines over recent years. Table 3 presents age-standardized mortality rates for all ages, groups 25-44, 45-64, 65-74 and 75þ years age groups for lung cancer in 2005-2009 and 2010-2014, the predicted rates for 2017 and the percent difference between 2012 and 2017. Men showed favourable patterns at all age groups and in all countries, generally larger in the young. With a few exceptions, rates were predicted to decline also in women, though generally not as much as for men. Figure 4 shows the estimated number of avoided cancer deaths in men and women between 1990 and 2017, assuming constant age-specific rates in 1990 (light grey area). Over the 27-year period considered, a substantial number of cancer deaths was avoided in Argentina (132 000 deaths, 88 000 in men and 44 000 in women), Chile (63 000 deaths, 16 000 in men and 47 000 in women), Colombia (83 000 deaths, 31 000 in men and 52 000 in women), Mexico (118 000 deaths, 39 000 in men and 79 000 in women) and Venezuela only for women (26 000 deaths). No appreciable reduction in cancer deaths was observed in Brazil and Cuba (not shown), and Venezuelan men. 
Discussion
Despite substantial variability across the seven Latin America countries considered (i.e. for all cancers in 2012 there was an about 2-fold difference between the lowest rate in Mexico and the highest one in Cuba for men, and an over 50% difference in women), rates for all cancers and for most major cancer sites are predicted to fall to 2017, confirming the global decrease in cancer mortality over recent decades [11] . However, as in most other areas of the world with the exception of the USA and a few western European countries [4, 12] , the total number of cancer deaths Continued is still rising, reflecting the lower rate of falls as compared to the USA [3] and the EU [4] , as well the increasing size and ageing of the population. Total cancer mortality rates in Argentina, Cuba and Chile were similar to those registered in Europe, North America and (for men) in Japan [11] , but they were appreciably lower for both sexes in other Latin American countries considered. This essentially reflects the historical low lung cancer (and most likely other tobacco related cancers) rates in these countries, due to less frequent cigarette use [13] [14] [15] [16] . However, in Cuba female lung cancer rates are higher than the EU ones, and not appreciably different from the North American ones [11] , and rates are predicted to fall only modestly, contrary to the US ones [3] .
Despite predicted continuous falls, stomach cancer rates remain high in Latin America (particularly so in Chile) [11] . This likely reflects the high prevalence of Helicobacter Pylori (HP) Deaths rates per 100,000 Deaths rates per 100,000
Deaths rates per 100,000
Deaths rates per 100,000 Deaths rates per 100,000 Deaths rates per 100,000 Table 3 . During the 27-year period, a total of over 420 000 cancer deaths have been avoided in five of the seven countries considered (174 000 in men and 248 000 in women). No reduction in cancer deaths was registered in Brazil, Cuba and Venezuelan men. In 2017 alone, about 30 000 deaths are predicted to be avoided in men, but none in Cuba, and about 26 000 in women, but none in Brazil and Cuba. Abbreviation: ASR, age specific rate.
infection [17, 18] as well as the interaction between HP, unfavourable dietary habits and poor food preservation [19] . A meta-analysis of Latin American case control studies [20] confirmed the role of local dietary factors, i.e. meat, preserved meat, salt and chili pepper on gastric cancer. In most of Latin America, and particularly in Mexico, colorectal cancer rates are much lower than in other areas of the world [11] , despite a high prevalence of overweight and obesity [21, 22] . This likely reflects favourable aspects of local diet and possibly physical activity [23] .
Pancreatic cancer mortality has not been increasing in most Latin American countries. This is consistent with the favourable patterns and trends of other tobacco-related cancers, since tobacco is the strongest recognized risk factor for this neoplasia, too [24] . Pancreatic cancer remains particularly difficult to diagnose, and hence a proportion of under-certification in some of the countries considered remains possible.
Breast cancer mortality has substantially declined in Europe and North America [3, 5] over the last few decades, following improvements in diagnosis and treatment. Most Latin American rates are comparably low, and show favourable predictions [25] [26] [27] . The low rates in Mexico are probably real, since breast cancer is easy to diagnose, and low breast cancer rates in these ethnic groups are registered in the USA as well [28] [29] [30] .
We were unable to distinguish cervical from endometrial cancer from death certification data. The high rates in Latin America, however, are attributable to high cervical cancer [31] in this area. The predicted rates remain high on a global scale, despite substantial declines in all countries except Cuba. This underlines the persisting importance of prevention for this neoplasms [2, 32] , through screening and-for younger generations-HPV vaccination.
For prostate cancer, the predicted rates are favourable, reflecting, as in other areas of the world with similar rates, improved management [33] . Likewise, the favourable predictions in leukaemia rates are attributable to improved treatment of the disease [5, [34] [35] [36] .
Over the last three decades, there was no appreciable number of cancer deaths avoided in Brazil and Cuba-despite the high rates in Cuba-as well as in men from Venezuela. This points to the urgency of improving cancer prevention and management in these countries [37] . The total number of avoided deaths in the other four countries plus Venezuelan women was over 420 000. This may be an underestimate, assuming that cancer deaths certification accuracy has improved over the last three decades. In proportional terms, this was less than in the USA and in the EU, but is at least in part justified by the comparatively low rates of several cancers in Latin America.
Data available in the WHO database allowed analysis of trends and predictions for major cancers only in a proportion of Latin American countries, though these cover the majority of Latin American population. In some of the countries considered, validity of death certification may be subject to criticism, though we included only countries with acceptable indicators of death certification validity in the WHO database, and a selected number of major neoplasms relatively easy to diagnose and hence certify. In addition, this cannot explain the favourable predicted trends. It is moreover reassuring that the presented cancer rates and patterns are consistent with those of selected groups of Hispanic whites in Florida, i.e. Mexican, Cuban, Central America, South America [30] . Another inherent limitation of predictions is their inability to model sudden changes or fluctuation in slope. These limitations notwithstanding, the general pattern emerging from the present work is of continuing, though modest, declines in cancer mortality in Latin America, with the exception of Cuba [30] .
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